DAROLUTAMIDE Tablets

{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2028-06-14T23:59:59+01:00",
        "startDate": "2025-06-30T00:00:00+01:00"
      },
      "documents": [
        {
          "datePublished": "2025-06-26T11:06:05+01:00",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "035325-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/035325-2025"
        }
      ],
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Pharmaceutical products",
              "id": "33600000",
              "scheme": "CPV"
            }
          ],
          "deliveryAddresses": [
            {
              "country": "GB",
              "countryName": "United Kingdom",
              "region": "UKN"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "milestones": [
        {
          "dueDate": "2025-06-26T23:59:59+01:00",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-COH-00935048",
          "name": "BAYER PUBLIC LIMITED COMPANY"
        }
      ],
      "title": "Darolutamide 300mg tablets",
      "value": {
        "amount": 270000,
        "amountGross": 324000,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PBRP-6676-CQZY",
    "name": "Northern Health And Social Care Trust"
  },
  "date": "2025-06-26T11:06:05+01:00",
  "id": "035325-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-0553fb",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Antrim",
        "postalCode": "BT41 2RL",
        "region": "UKN0D",
        "streetAddress": "Brettan Hall, Antrim Area Hospital, Bush Road"
      },
      "contactPoint": {
        "email": "diane.trimble@northerntrust.hscni.net"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          },
          {
            "description": "Northern Irish devolved regulations apply",
            "id": "GB-NIR",
            "scheme": "UK_CA_DEVOLVED_REGULATIONS"
          }
        ]
      },
      "id": "GB-PPON-PBRP-6676-CQZY",
      "identifier": {
        "id": "PBRP-6676-CQZY",
        "scheme": "GB-PPON"
      },
      "name": "Northern Health And Social Care Trust",
      "roles": [
        "buyer"
      ]
    },
    {
      "additionalIdentifiers": [
        {
          "id": "PWRY-2527-LDRY",
          "scheme": "GB-PPON"
        }
      ],
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Reading",
        "postalCode": "RG2 6AD",
        "region": "UKJ11",
        "streetAddress": "400 South Oak Way"
      },
      "contactPoint": {
        "email": "andrew.asbury@bayer.com"
      },
      "details": {
        "scale": "large",
        "url": "http://www.bayer.co.uk",
        "vcse": false
      },
      "id": "GB-COH-00935048",
      "identifier": {
        "id": "00935048",
        "scheme": "GB-COH"
      },
      "name": "BAYER PUBLIC LIMITED COMPANY",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "The intended contract is for the supply of Darolutamide 300mg tablets to Northern Health and Social Care Trust for up to three years.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "DAC131/0525PM",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Purchase of drugs which are subject to patent protection/\nSole MA Holder, where no reasonable alternative or substitute exists. \nSection 41 schedule 5(5) of the PA2023 permits a direct\naward in the case of single supplier and permits the award\nif the following conditions are met in relations to the public\ncontract -\n(a)due to a particular supplier having intellectual property\nrights or other exclusive rights, only that supplier can\nsupply the goods, services or works required, and\n(b)there are no reasonable alternatives to those goods,\nservices or works.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersIntellectualPropertyExclusiveRights"
      }
    ],
    "riskDetails": "Spend on previous DAC totaling \u00a3119955. \nAggregate value is \u00a3389,955.",
    "status": "complete",
    "title": "DAROLUTAMIDE Tablets"
  }
}